CMSA Executive Sponsor Highlight

Print this Article | Send to Colleague

Boehringer Ingelheim Pharmaceuticals, Inc., the US subsidiary of Boehringer Ingelheim, headquartered in Germany, operates globally in 50 countries with more than 41,500 employees.

The company is committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

For more information please visit http://us.boehringer-ingelheim.com.